+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Advancements in Obesity Therapies and Diabetes Research · Registering as Listener

ICAOTDR
📅 2 – 3 Feb 2027 📍 Utrecht, Netherlands 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Advancements in Obesity Therapies and Diabetes Research
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 2 SDG 3 SDG 4 SDG 9

This session will explore the complex relationship between obesity and type-2 diabetes, focusing on the underlying biological mechanisms. Participants will discuss recent findings that elucidate how obesity contributes to the onset and progression of diabetes.

This track will address the rising prevalence of childhood obesity and its implications for type-2 diabetes. Experts will present innovative prevention and intervention strategies aimed at reducing obesity rates among children.

This session will focus on the various surgical options available for patients suffering from obesity-related diabetes. Discussions will include the efficacy, risks, and long-term outcomes of bariatric surgery in this population.

This track will highlight the latest advancements in pharmacological therapies for obesity management. Researchers will present data on new medications and their mechanisms of action in promoting weight loss.

This session will examine the role of lifestyle changes and behavioral counseling in the management of obesity and diabetes. Participants will share evidence-based strategies for effective weight management through lifestyle interventions.

This track will delve into the metabolic complications that arise from obesity, including insulin resistance and dyslipidemia. Experts will discuss the implications of these complications for diabetes management.

This session will explore the impact of physical activity on obesity and its related health outcomes. Researchers will present findings on exercise interventions and their effectiveness in weight loss and diabetes control.

This track will focus on the psychological factors influencing obesity and diabetes management. Discussions will include the importance of mental health support and counseling in achieving sustainable weight loss.

This session will explore traditional Ayurvedic treatments and their relevance in contemporary obesity management. Experts will discuss the integration of Ayurvedic principles with modern therapeutic strategies.

This track will showcase cutting-edge research in the fields of obesity and diabetes. Researchers will present their latest findings and discuss future directions for investigation.

This session will provide an overview of current pharmacologic therapies for obesity and their clinical applications. Experts will discuss the challenges and future prospects for drug development in this area.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED